Intratec Solutions has released a report analyzing the production costs of methionine hydroxy analog, based on a process from acrolein, methyl mercaptan and hydrogen cyanide. The report covers capital and operating costs and can be extended with capacity and country-specific analyses.
It is a commercial research product rather than a market event.
Production cost studies help buyers gauge the cost floor for methionine hydroxy analog, but this release does not change supply or demand. Any price impact is negligible.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.